NeurogesX Inc·4/A

Sep 19, 5:00 PM ET

Markels Michael 4/A

4/A · NeurogesX Inc · Filed Sep 19, 2012

Insider Transaction Report

Form 4/AAmended
Period: 2012-09-01
Markels Michael
VP, Commercial Ops and Bus Dev
Transactions
  • Award

    Common Stock

    2012-09-01$0.25/sh+15,000$3,75069,873 total
Footnotes (3)
  • [F1]Issuance of common stock upon vesting of certain performance share awards on September 1, 2012.
  • [F2]Amount of securities beneficially owned following the reported transaction includes 1,333 shares acquired on November 15, 2011 under the NeurogesX, Inc. Amended and Restated 2007 Employee Stock Purchase Plan.
  • [F3]The amount of securities beneficially owned had been over reported on September 5, 2012 filing, this amendment updates such beneficially owned securities.

Documents

1 file
  • 4
    rrd356584.xml

    FORM 4/A